Get the live share price of Abbott Laboratories (ABT), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.
Zacks Investment Research on MSN
Here is what to know beyond why Abbott Laboratories (ABT) is a trending stock
Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Zacks Investment Research on MSN
Abbott (ABT) rises higher than market: Key facts
Abbott (ABT) closed at $126.45 in the latest trading session, marking a +1.82% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.64%. At the same time, the Dow added 1.23%, and ...
Members of Congress have traded $ABT stock 13 times in the past 6 months. Of those trades, 6 have been purchases and 7 have been sales. Here’s a breakdown of recent ...
Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500’s 6% rise. This strong performance is due to the ...
Abbott (ABT) ended the recent trading session at $135.87, demonstrating a -0.07% swing from the preceding day's closing price. This change was narrower than the S&P 500's 1.59% loss on the day.
Abbott Laboratories (NYSE:ABT – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $111.93 and traded as high ...
Abbott Laboratories ABT recently received FDA approval for its Volt PFA System to treat patients battling atrial fibrillation ...
A more conservative goal of $100 monthly dividend income would require 508 shares of Abbott. An investor would need to own $325,274 worth of Abbott Laboratories to generate a monthly dividend income ...
Discover why Abbott Laboratories (ABT) earns a buy rating with strong fundamentals, dividend growth, and growth prospects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results